Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
4,987,748
Value
$212.9M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of BSX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,987,748$212.9M0.1%+770,434+18.3%AddedHolders
Q1 20264,217,314$264.6M0.2%−558,304−11.7%ReducedHolders
Q4 20254,775,618$455.4M0.3%−4,130,627−46.4%ReducedHolders
Q3 20258,906,245$869.5M0.7%+3,501,940+64.8%AddedHolders
Q2 20255,404,305$580.5M0.5%−29,250−0.5%ReducedHolders
Q1 20255,433,555$548.1M0.5%+502,103+10.2%AddedHolders
Q4 20244,931,452$440.5M0.4%−4,861,651−49.6%ReducedHolders
Q3 20249,793,103$820.7M0.9%−2,706,764−21.7%ReducedHolders
Q2 202412,499,867$962.6M0.9%+3,725,802+42.5%AddedHolders
Q1 20248,774,065$600.9M0.6%−207,469−2.3%ReducedHolders
Q4 20238,981,534$519.2M0.5%−12,174,688−57.5%ReducedHolders
Q3 202321,156,222$1.12B1.2%+5,699,874+36.9%AddedHolders
Q2 202315,456,348$836.0M0.9%+444,201+3.0%AddedHolders
Q1 202315,012,147$751.1M0.8%+8,477,836+129.7%AddedHolders
Q4 20226,534,311$302.3M0.3%−7,957,191−54.9%ReducedHolders
Q3 202214,491,502$561.3M0.7%+1,960,393+15.6%AddedHolders
Q2 202212,531,109$467.0M0.6%−412,621−3.2%ReducedHolders
Q1 202212,943,730$573.3M0.7%+6,424,582+98.5%AddedHolders
Q4 20216,519,148$276.9M0.3%+1,785,342+37.7%AddedHolders
Q3 20214,733,806$205.4M0.2%−747,071−13.6%ReducedHolders
Q2 20215,480,877$234.4M0.2%+4,646,664+557.0%AddedHolders
Q1 2021834,213$32.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.